Correspondence on 'Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'
- PMID: 33504479
- DOI: 10.1136/annrheumdis-2021-219904
Correspondence on 'Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'
Keywords: COVID-19; biological therapy; epidemiology.
Conflict of interest statement
Competing interests: None declared.
Comment in
- 
  
  Response to: 'Correspondence on 'Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'' by Lee.Ann Rheum Dis. 2023 Apr;82(4):e84. doi: 10.1136/annrheumdis-2021-219918. Epub 2021 Jan 27. Ann Rheum Dis. 2023. PMID: 33504478 No abstract available.
Comment on
- 
  
  Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis.Ann Rheum Dis. 2021 Mar;80(3):384-391. doi: 10.1136/annrheumdis-2020-218946. Epub 2020 Oct 13. Ann Rheum Dis. 2021. PMID: 33051220
Publication types
MeSH terms
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
- Medical
 
        